as on October 23, 2025 at 1:29 am IST
Day's Low
Day's High
2.74%
Downside
2.99%
Upside
52 Week's Low
52 Week's High
26.56%
Downside
141.90%
Upside
Check Foghorn Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$228.4M
EPS (TTM)
-1.1633
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.05
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-88.7M
Revenue (TTM)
24.2M
Profit Margin
0.00%
Return On Equity TTM
24719300.00%
Track how Foghorn Therapeutics Inc P/E has moved over time to understand its valuation trends.
Foghorn Therapeutics Inc in the last 5 years
Lowest (-6.03x)
September 30, 2025
Today (-5.05x)
October 22, 2025
Industry (-0.88x)
October 22, 2025
Highest (-1.75x)
June 30, 2021
Today’s Price to Earnings Ratio: -5.05x
Compare market cap, revenue, PE, and other key metrics of Foghorn Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $228.4M | NA | -5.05 | 0.00% | |
BUY | $64.4B | 252.94% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $107.5B | 102.91% | 29.68 | 31.86% | |
BUY | $61.3B | 0.63% | 14.58 | 31.37% |
The Foghorn Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Foghorn Therapeutics Inc investment value today
Current value as on today
₹57,670
Returns
Returns from Foghorn Therapeutics Inc Stock
Dollar Returns*
₹4,557 (+4.56%)
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Foghorn Therapeutics Inc. Average target price of $11.67
Get share price movements and forecasts by analysts on Foghorn Therapeutics Inc.
What analysts predicted
65.64%UPSIDE
Target Price
$11.67
Current Price
$4.01
Analyzed by
11 Analysts
Target
$11.67
Foghorn Therapeutics Inc target price $11.67, a slight upside of 65.64% compared to current price of $4.01. According to 11 analysts rating.
Search interest for Foghorn Therapeutics Inc Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -19.50M → -17.93M (in $), with an average increase of 4.3% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 2.85M → 7.55M (in $), with an average increase of 36.6% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 184.1%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 106.0%
Price Dip
In the last 1 month, FHTX stock has moved down by -18.3%
Organisation | Foghorn Therapeutics Inc |
Headquarters | 500 Technology Square, Cambridge, MA, United States, 02139 |
Industry | Health Technology |
CEO | Mr. Adrian H. B. Gottschalk |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Alfonso Quintas Cardama M.D. | Chief Medical Officer |
Dr. Gerald R. Crabtree M.d. | Founder & Member of Scientific Advisory Board |
Ms. Karin Hellsvik | Chief of Staff to the CEO, VP of Corporate Affairs & Investor Relations |
Mr. Carlos Costa | Chief People Officer |
Dr. Steven F. Bellon Ph.D. | Chief Scientific Officer |
Mr. Michael J. LaCascia J.D. | Chief Legal Officer |
Mr. Saurabh Sewak Ph.D. | Vice President of Corporate Development |
Mr. Adrian H. B. Gottschalk | President, CEO & Director |
Mr. Kristian Humer M.B.A. | Chief Financial Officer |
Dr. Anna Rivkin Ph.D. | Chief Business Officer |
Foghorn Therapeutics Inc share price today is $4.01 as on at the close of the market. Foghorn Therapeutics Inc share today touched a day high of $4.13 and a low of $3.9.
Foghorn Therapeutics Inc share touched a 52 week high of $9.7 on and a 52 week low of $2.94 on . Foghorn Therapeutics Inc stock price today i.e. is closed at $4.01,which is 58.66% down from its 52 week high and 36.17% up from its 52 week low.
Foghorn Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Foghorn Therapeutics Inc (FHTX) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Foghorn Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Foghorn Therapeutics Inc share’s latest price of $4.01 as on October 23, 2025 at 1:29 am IST, you will get 2.4938 shares of Foghorn Therapeutics Inc. Learn more about
fractional shares .